Churchill Management’s Zimmer Biomet ZBH Stock Holding History

Churchill Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-53,628	Closed	-$8.37M	–	162
2021 Q2	$8.37M	Buy	+53,628	New	+$8.69M	0.12%	98
2015 Q3	–	Sell	-29,560	Closed	-$3.13M	–	191
2015 Q2	$3.13M	Sell	29,560 -16,125	-35%	-$1.78M	0.11%	102
2015 Q1	$5.21M	Buy	45,685 +12,105	+36%	+$1.38M	0.18%	79
2014 Q4	$3.7M	Sell	33,580 -1,882	-5%	-$198K	0.15%	95
2014 Q3	$3.46M	Buy	35,462 +2,929	+9%	+$288K	0.14%	86
2014 Q2	$3.28M	Buy	32,533 +3,331	+11%	+$325K	0.15%	80
2014 Q1	$2.68M	Sell	29,202 -18,861	-39%	-$1.74M	0.11%	91
2013 Q4	$4.35M	Buy	+48,063	New	+$4.16M	0.17%	49

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Churchill Management's ZBH Position: Q3 2021 in Review

Churchill Management sold out of Zimmer Biomet (ZBH) in Q3 2021, closing a stake of 53,628 shares — an estimated $8.37M sold.

Churchill Management first reported a position in ZBH in Q4 2013 and held it in 8 quarters. The position peaked at $8.37M in Q2 2021. 982 funds tracked by Wall St. Rank hold ZBH as of Q3 2021.

Churchill Management reported no remaining Zimmer Biomet position as of Q3 2021 after selling out during the quarter.
Churchill Management sold 53,628 Zimmer Biomet shares in Q3 2021, an estimated $8.37M.
Churchill Management first reported a position in Zimmer Biomet in Q4 2013 and held it in 8 quarters.
Churchill Management's Zimmer Biomet position peaked at $8.37M in Q2 2021.
982 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2021.

Based on Churchill Management's 13F filing for Q3 2021, filed 13 Oct 2021.